Episode 54
Biotech Hangout
00:00
CMS Negotiations: Is It Too Early to Make Strong Decisions?
The overall conclusion though was despite these issues and ways to navigate around it which aren't great. These companies are still looking for great drugs. So too early to make any strong conclusions other than the fact that we're sort of going the wrong way, right? Is that not really sure the system understands or gets what's going on here? Make sense? Yeah.
Transcript
Play full episode
